Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery [NA]

View source ↗

Summary

This completed clinical trial evaluated whether dipeptidyl peptidase-4 inhibitors promote alpha-cell recovery in individuals with Type 1 diabetes, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Dipeptidyl peptidase-4 inhibitors

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: COMPLETED | Results posted: 2014-02-17